Sales 2024 * | 29.36M 2.35B | Sales 2025 * | 95.29M 7.61B | Capitalization | 202M 16.11B |
---|---|---|---|---|---|
Net income 2024 * | -68M -5.43B | Net income 2025 * | -13M -1.04B | EV / Sales 2024 * | 6.87 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.12 x |
P/E ratio 2024 * |
-2.99
x | P/E ratio 2025 * |
-11.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.91% |
Latest transcript on KemPharm, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Christal Mickle
FOU | Founder | 45 | 29/10/06 |
Neil McFarlane
CEO | Chief Executive Officer | 51 | 09/10/23 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 31/03/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 24/04/23 |
Tamara Favorito
CHM | Chairman | 65 | 17/08/21 |
Director/Board Member | 56 | 24/04/23 |
1st Jan change | Capi. | |
---|---|---|
+7.91% | 72.81B | |
+12.64% | 9.13B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
+20.84% | 2.42B | |
-26.13% | 2.32B | |
+19.31% | 2.17B |